Costs and economic impact of four autoimmune diseases in a cohort of Colombian patients

Medicine & Life Sciences

1. Costs and Cost Analysis 100%
2. Economics 74%
3. Cost of Illness 38%
4. Autoimmune Diseases 27%
5. Colombia 25%
6. Health 20%
7. Quality of Life 20%
8. ametantrone 16%
9. Pathology 13%
10. Quality-Adjusted Life Years 11%
11. Administrative Personnel 10%
12. Congresses 10%
13. Developed Countries 10%
14. Systemic Lupus Erythematosus 10%
15. Health Care Costs 9%
16. Multiple Sclerosis 9%
17. Health Services 9%
18. Organizations 8%
19. Publications 8%
20. Rheumatoid Arthritis 8%
21. Demography 6%
22. Physicians 6%
23. Growth 5%